We investigated a useful chemical index for an excessive nicotinamide intake and how this excessive nicotinamide intake affects the tryptophan-nicotinamide metabolism in rats. Weaning rats were fed on a tryptophan-limited and nicotinic acid-free diet containing no, 0.003%, 0.1%, 0.2%, or 0.3% nicotinamide for 21days. Urine samples were collected on the last day and analyzed the intermediates and metabolites on the tryptophan-nicotinamide pathway. Nicotinamide N-oxide, nicotinic acid and nicotinuric acid, metabolites of nicotinamide, were detected when nicotinamide at more than 0.1% had been taken. An intake of nicotinamide of more than 0.1% increased the urinary excretion of quinolinic acid, an intermediate on the pathway. Nicotinamide N-oxide and nicotinuric acid increased with increasing dietary concentration of nicotinamide. These results show that the measurements of nicotinamide N-oxide and nicotinuric acid in urine would be useful indices for an excessive nicotinamide intake.
Some people have recently been taking mega-vitamins for health. Niacin is needed to maintain a healthy body, but an excess of niacin causes an adverse effect. 1) Supplementation of the diet with 0.5% nicotinamide in rats has caused growth inhibition, 2) and an intake of 9 g/ day of nicotinamide by a patient caused hepatotoxicity. 3) To prevent the risk of adverse health effects from an excessive vitamin intake, the Ministry of Health, Labour and Welfare has defined the Tolerable Upper Intake Levels as the highest level of daily nutrient intake that is likely to pose no risk of adverse health effects on almost all individuals in the general population. 4) Furthermore, useful chemical indices of an excessive vitamin intake prior to revealing a toxic effect are also needed. We have previously reported the possibility that the urinary excretion of nicotinamide N-oxide and nicotinuric acid (NuA) would be useful indices for an excessive intake of niacin. 2, 5) Nicotinamide is biosynthesized from tryptophan in the liver, 6) and this tryptophan-nicotinamide pathway plays an important role in the supply of pyridine nucleotides. The tryptophan-nicotinamide pathway consists of two parts, the tryptophan--amino--carboxymuconate-"-semialdehyde (ACMS) pathway and the ACMS-NAD pathway, since the tryptophan-nicotinamide pathway branches at ACMS into the ACMS-NAD pathway and the ACMS-acetyl CoA pathway (Fig. 1) . Numerous factors such as pregnancy, 7) nutrition, [8] [9] [10] [11] [12] [13] [14] [15] hormones, [16] [17] [18] [19] [20] chemicals, [21] [22] [23] [24] [25] [26] and experimental models of diseases [27] [28] [29] affect this conversion from tryptophan to nicotinamide. However, little is known about the association between the nicotinamide intake and tryptophan-nicotinamide pathway.
To determine a better index for an excessive nicotinamide intake, we assessed the urinary excretion of nicotinamide metabolites, including nicotinamide Noxide, NuA and nicotinic acid, by rats fed with a 0.1%, 0.2%, or 0.3% nicotinamide diet. To determine how an excessive nicotinamide intake would affect the tryptophan-nicotinamide pathway, we also investigated the urinary excretion of metabolites on the pathway by rats fed with an excessive nicotinamide.
Materials and Methods
Chemicals. NAD þ and NADP þ were purchased from Sigma Chemical Company (St. Louis, MO, USA). Vitamin-free milk casein, gelatinized cornstarch, sucrose, L-methionine, nicotinic acid, nicotinamide and quinolinic acid (QA) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Kynurenic acid (KA), anthranilic acid (AnA), xanthurenic acid (XA), 3-hydroxyanthranilic acid and N 1 -methylnicotinamide (MNA) chloride were purchased from Tokyo Kasei Kogyo (Tokyo, Japan). N 1 -methyl-2-pyridone-5-y To whom correspondence should be addressed. Tel: +81-749-28-8454; Fax: +81-749-28-8601; E-mail: fukkie@shc.usp.ac.jp Abbreviations: NuA, nicotinuric acid; QA, quinolinic acid; MNA, N 1 -methylnicotinamide; 2-Py, N 1 -methyl-2-pyridone-5-carboxamide; 4-Py, N 1 -methyl-4-pyridone-3-carboxamide; KA, kynurenic acid; XA, xanthurenic acid; 3-HA, 3-hydroxyanthranilic acid; AnA, anthranilic acid; ACMS, -amino--carboxymuconate-"-semialdehyde; AMS, -aminomuconate-"-semialdehyde carboxamide (2-Py) and N 1 -methyl-4-pyridone-3-carboxamide (4-Py) were respectively synthesized by the methods of Pullman and Colowick 30) and Shibata et al. 31) NuA and nicotinamide N-oxide were purchased from Aldrich Chemical (Milwaukee, WI, USA), and corn oil was purchased from Ajinomoto (Tokyo, Japan). The mineral and vitamin mixtures were obtained from Oriental Yeast Kogyo (Tokyo, Japan), all the other chemicals used being of the highest purity available from commercial sources.
Animals. The care and treatment of the experimental animals conformed to The University of Shiga Prefecture guidelines for the ethical treatment of laboratory animals. Male rats of the Wistar strain (3 weeks old with a body weight of around 40 g) were obtained from Clea Japan (Tokyo, Japan) and immediately placed in individual metabolic cages (CT-10; Clea Japan). They were then divided into five groups and fed ad libitum for 21 days with a nicotinic acid-free and tryptophanlimited diet with no, 0.003%, 0.1%, 0.2%, or 0.3% nicotinamide added. The diet without nicotinamide was defined as the deficient diet, with 0.003% as the control diet, and with 0.1, 0.2, or 0.3% as the excess nicotinamide diet. The composition of the diets is shown in Table 1 .
The room temperature was maintained at around 20 C and about 60% humidity, and a 12-hr light/12-hr dark cycle was maintained. Body weight and food intake were measured daily at around 10:00 a.m. Urine samples (24-hr; 10:00 a.m.-10:00 a.m.) on the last day were collected in amber bottles containing 1 ml of 1 M HCl, and were stored at À25 C until needed. The rats were killed by decapitation at around 10:00 a.m. on the last day of the experiment, and a 20-l sample of blood was taken from the carotid artery of each and treated as Dashed lines are not expressed in the normal state by rats. ACMS, -amino--carboxymuconate-"-semialdehyde; AMS, -aminomuconate-"-semialdehyde. 32) for measuring NAD (NAD þ + NADH) and NADP (NADP þ + NADPH). To measure NAD and NADP in the liver, the liver of each animal was dissected, and a portion (approximately 0.2 g) was immediately treated as described in the literature. 33) Analyses. The contents of NAD (NAD þ + NADH) and NADP (NADP þ + NADPH) were measured by the colorimetric methods of Shibata and Murata 32) and Shibata and Tanaka, 33) respectively. The contents of nicotinamide and of the catabolic metabolites, 2-Py and 4-Py, in the urine were simultaneously measured by the HPLC method of Shibata et al., 31) while the content of MNA in the urine was measured by the HPLC method of Shibata.
34) The contents of nicotinic acid and NuA in the urine were simultaneously measured by the HPLC method of Shibata, 35) while that of nicotinamide N-oxide was measured by the method of Shibata.
36)
The contents of KA, 37) XA, 38) 3-HA, 38) AnA, 39) and QA 40) in the urine were measured by the HPLC method.
Results
Effects of an excess of nicotinamide on the body weight gain and food intake of weaning rats
The body weight gain and food intake of the rats fed on the nicotinic acid-free and tryptophan-limited diet (deficient diet) were the lowest of the groups (Fig. 2) . The highest growth and food intake was observed with the group fed on the 0.003% nicotinamide-added diet (control diet). The growth and food intake of the groups fed on the diets containing 0.1%, 0.2%, and 0.3% nicotinamide were slightly lower than the control diet group, but there was no significant difference compared with those of the control group. The total food intake was 109:0 AE 6:0, 205:7 AE 5:9, 188:3 AE 9:2, 183:6 AE 9:9 and 176:0 AE 9:8 g/21 days for the deficient diet, control diet, 0.1% nicotinamide, 0.2% nicotinamide and 0.3% nicotinamide groups, respectively.
Effects of excess nicotinamide administration on the urinary excretion of compounds in the upper parts of tryptophan-nicotinamide pathway
Feeding an excess of nicotinamide in the diet did not affect the urinary excretion of KA, AnA, XA, 3-HA, related compound or intermediates on the tryptophan-ACMS pathway (Table 2 ). In contrast, excess nicotinamide administration increased the urinary excretion of QA with increasing concentration of nicotinamide in the diet ( Table 2) .
Effects of excess nicotinamide administration on the urinary excretion of nicotinamide catabolites
The urinary excretion of such nicotinamide catabolites as MNA, 2-Py and 4-Py was increased by the intake of excess nicotinamide (Table 3) . However, the excretion of each catabolite was not dependent on the concentration of nicotinamide in the diet. Although no urinary excretion of nicotinic acid, NuA or nicotinamide N-oxide was detected in the control group, they were detected when the rats were fed with an excess of nicotinamide in the diet. The urinary excretion of NuA and nicotinamide N-oxide increased with increasing concentration of nicotinamide in the diet. Therefore, these metabolites could be used as indices for an excess nicotinamide intake. The percentage of the total urinary , tryptophan-limited and nicotinic acid-free diet (deficient diet); , tryptophan-limited and nicotinic acid-free dietþ0:003% nicotinamide (control diet); , tryptophan-limited and nicotinic acid-free dietþ0:1% nicotinamide; , tryptophan-limited and nicotinic acid-free dietþ0:2% nicotinamide; , tryptophan-limited and nicotinic acid-free dietþ0:3% nicotinamide. Weaning male rats of the Wistar strain purchased from Clea Japan were individually housed in galvanized metabolic cages and fed with ad libitum one of the diets listed in Table 1 and water throughout the experimental period. Each point is the mean AE SEM for 4 rats; a different superscript letter on the last day means significant difference at p<0:05, as calculated by the Student-Newman-Keuels multiple-comparison test. excretion of nicotinamide catabolites for the nicotinamide intake was similar with the 0.1%, 0.2%, and 0.3% added-nicotinamide diets.
Effects of excess nicotinamide administration on the concentrations of NAD and NADP in the liver and blood
The liver NAD content was increased by the intake of excess nicotinamide up to 0.1%, but any greater excess did not give a further increase in liver NAD (Table 4) . However, the blood NAD content increased with increasing dietary concentration of nicotinamide. These results show the different control mechanisms for NAD between the liver and blood. The NADP contents in the liver and blood were little different among the groups (Table 4) .
Discussion
This study investigated the nicotinamide catabolism in rats fed with excess nicotinamide. Our results clearly show that administration of excess nicotinamide increased the urinary excretion of total nicotinamide catabolites in a dose-dependent manner (Table 3 ). In paticular, nicotinamide N-oxide, nicotinic acid and NuA were only detected in the urine with an excess nicotinamide intake, and the urinary excretion of nicotinamide N-oxide and NuA being increased with increasing dietary concentration of nicotinamide. However, the urinary excretion of other nicotinamide catabolites such as MNA, 2-Py and 4-Py was similar among the excess nicotinamide groups. The excretion of NuA from the 0.1% and 0.3% nicotinamide diets had a very high coefficient of variance, 66% with the 0.1% nicotinamide diet and 116% with the 0.3% nicotinamide diet, indicate of a difference in the ability to synthesis of NuA from nicotinic acid between individuals. This reaction needs glycine, ATP and CoA, and is catalyzed by two enzymes, 41) while the reaction from nicotinamide to nicotinamide N-oxide is catalyzed by one enzyme and does not need a co-substrate. 42) Therefore, the reaction would be little affected by factors other than the nicotinamide intake. Since the amount of nicotinamide N-oxide was 4-fold higher than that of NuA from the excess nicotinamide diets, we propose that the amount of nicotinamide N-oxide in the urine can be used as a chemical index for an excessive nicotinamide intake.
Previous studies have reported that nicotinamide Noxide, nicotinic acid or NuA was excreted into the rat urine by feeding a 0.5% nicotinamide-containing diet 2) or intraperitoneally injecting 70 mg (0.57 mmol) of nicotinic acid/kg of body weight. 43) Taken together with the results from the present study, it is suggested that excess niacin administration forms nicotinamide Noxide, nicotinic acid and NuA, and that these products are excreted into the urine. Although the urinary excretion of nicotinic acid and NuA was under the detectable limit when rats were fed on the 0.1% nicotinamide diet in the previous report, 2) the urinary excretion of nicotinic acid and NuA was detected in the present experiment. The experimental details such as the strain and age of the animals, and the composition of the diets between the two experiments were the same; therefore, the 0.1% nicotinamide diet would be the marginally maximum level to be normally metabolized.
The physiologically active compounds of nicotinamide are NAD þ , NADH, NADP þ , and NADPH. In the present experiment, the effects of nicotinamide intake on the contents of NAD (NAD þ + NADH) and NADP (NADP þ + NADPH) in the liver and blood were investigated. The excess nicotinamide diet increased the liver NAD content by 1.5-fold, although significantly, and the blood NAD content was increased. Enhancement of the tryptophan-nicotinamide metabolism by feeding with a phthalate ester has increased the liver NAD content by 1.5-fold, while the blood NAD level was not affected. 22) These results suggest that the blood NAD level is increased when the niacin pool in the liver becomes saturated. Therefore, the measurement of blood NAD might be useful for detecting an excess administration of niacin. The NADP (NADP þ + NADPH) contents in the liver and blood were not changed by an excessive nicotinamide intake ( Table 4 ), indicating that the concentration of NADP is rigidly controlled and might be more important than that of NAD. The results of the present experiment clearly showed that nicotinamide had no affect on any compound on the tryptophan-ACMS pathway, indicating that the metabolism of tryptophan to ACMS independently operates with a supply of nicotinamide (Table 2) . ACMS is an unstable intermediate, and the tryptophan-ACMS pathway branches at this metabolite; one branch is the reaction from ACMS to -aminomuconate-"-semialdehyde (AMS) catalyzed by ACMS decarboxylase, and the other is the reaction from ACMS to QA by spontaneous autocyclization. AMS is then metabolized into acetyl CoA via glutaryl CoA, while QA is converted to nicotinate mononucleotide in the presence of 5-phosphoribosyl 1-pyrophosphate catalyzed by quinolinate phosphoribosyltransferase. In the present experiment, the urinary excretion of QA was increased by the excessive nicotinamide intake ( Table 2 ). This phenomenon is the first observation, and there are two possibilities for its occurrence. One is 5-phosphoribosyl 1-pyrophosphate competition between QA and nicotinamide, and the other is the increased QA formation caused by a metabolite of nicotinamide that inhibits ACMS decarboxylase. Taken together with the results that feeding the excess nicotinamide diet did not affect the urinary excretion of KA, AnA, XA or 3-HA (Table 2) , the former seems to be the most plausible. Measuring the mRNA expression or activity of ACMS decarboxylase in rats fed with an excess of nicotinamide is nessesary to elucidate the latter possibility. The tryptophan-ACMS pathway and NAD cycle might be accidentally concatenated; nevertheless, the tryptophan-ACMS pathway is the critical route for supplying nicotinamide.
In summary, although the oxidative degradation pathway of tryptophan is considered to be the supply route of nicotinamide, an excessive nicotinamide intake did not show any affect on the metabolism of tryptophan-ACMS. However, our results indicate that the NAD cycle is related to QA metabolism. Another aim of the present experiment was to find useful indices for an excessive nicotinamide intake. Nicotinamide N-oxide, nicotinic acid and NuA were detected in the urine after the intake of excessive nicotinamide, and the urinary excretion of nicotinamide N-oxide was particularly sensitive to this excess of nicotinamide. We propose that the measurement of nicotinamide N-oxide in urine could be used to an assess the excessive nicotinamide intake.
